Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 178Congress 0Executive branch 0Insiders 178
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · $15K+ · 178 trades

Trades
178
Buys 0 · Sells 178
People
20
Stocks
1
Disclosed value
$56M
range midpoints · Congress & executive
Filed late
13
  1. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  2. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  3. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  4. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  5. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$1.4Mdisclosed Sep 9 · filed 1 day after the trade
  6. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  7. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  8. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  9. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  10. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  11. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  12. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  13. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$206Kdisclosed Sep 9 · filed the same day
  14. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$274Kdisclosed Sep 9 · filed 5 days after the trade · late
  15. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  16. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  17. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  18. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  19. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  20. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  21. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  22. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  23. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  24. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  25. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade